Intervention

immunoenzyme technique

ClinicalTrials.gov intervention label

Clinical trials40
Recruiting0
Common conditions25
Lead sponsors shown15

Clinical trials

40 shown
Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast CancerNCT01219907 · 2012-06-01
WITHDRAWN
Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain MetastasesNCT00738335 · 2009-01-01
WITHDRAWN
Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone MetastasesNCT00634582 · 2009-01-01
TERMINATED
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerNCT00821964 · 2008-12-01
COMPLETED
Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast CancerNCT00847171 · 2008-12-01
COMPLETED
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast CancerNCT00892515 · 2008-10-01
COMPLETED
Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast CancerNCT00640861 · 2008-08-28
COMPLETED
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00729612 · 2008-08-14
COMPLETED
Blood Samples From Patients on a Clinical Trial to CINV During HSCTNCT00900068 · 2008-08-01
TERMINATED
Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal SyndromeNCT00938756 · 2008-04-01
UNKNOWN
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing SurgeryNCT00671476 · 2008-02-01
UNKNOWN
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male ParticipantsNCT00898274 · 2008-01-01
COMPLETED
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialNCT00904514 · 2007-10-01
TERMINATED
Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast CancerNCT00899197 · 2007-05-01
TERMINATED
Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerNCT00560495 · 2007-05-01
WITHDRAWN
Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast CancerNCT00470574 · 2007-03-20
COMPLETED
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the ProstateNCT00459407 · 2007-03-01
COMPLETED
Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast CancerNCT00897702 · 2007-01-09
COMPLETED
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and FormoterolNCT00569712 · 2007-01-01
COMPLETED
Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing SurgeryNCT01340599 · 2006-10-01
TERMINATED
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaNCT00398138 · 2006-10-01
COMPLETED
Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous TreatmentNCT00673569 · 2006-09-01
COMPLETED
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerNCT00436709 · 2006-07-01
UNKNOWN
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung CancerNCT00362882 · 2006-07-01
COMPLETED
Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIVNCT00381875 · 2006-07-01
COMPLETED
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)NCT00499083 · 2006-05-01
COMPLETED
Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast CancerNCT00689975 · 2006-02-01
COMPLETED
Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung CancerNCT00514215 · 2006-01-01
COMPLETED
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107NCT00898547 · 2005-11-01
TERMINATED
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate CancerNCT00089609 · 2005-04-19
COMPLETED
Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsNCT00389805 · 2005-03-01
COMPLETED
Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast CancerNCT00900133 · 2005-01-01
COMPLETED
Bortezomib and Topotecan in Treating Patients With Advanced Solid TumorsNCT00388089 · 2004-12-01
COMPLETED
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantNCT00361049 · 2004-09-01
COMPLETED
A Weight-Loss Program in Helping Obese Black Women Lose WeightNCT00859989 · 2004-07-01
UNKNOWN
Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast CancerNCT00896857 · 2004-04-01
COMPLETED
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu VaccineNCT00228358 · 2003-06-01
COMPLETED
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian CancerNCT00436254 · 2001-10-01
COMPLETED
Studying Blood Samples in Women With Breast Cancer or a History of Breast CancerNCT00898703 · 2001-08-01
COMPLETED
Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung CancerNCT00002667 · 1995-10-10
COMPLETED

Common conditions

Breast Cancer16Lung Cancer10Metastatic Cancer4Stage IV Breast Cancer4HER2-positive Breast Cancer3Unspecified Adult Solid Tumor, Protocol Specific3Cancer2Leukemia2Male Breast Cancer2Malignant Mesothelioma2Myelodysplastic Syndromes2Precancerous Condition2Prostate Cancer2Recurrent Breast Cancer2Recurrent Non-small Cell Lung Cancer2Stage I Prostate Cancer2Stage IV Non-small Cell Lung Cancer2Stage IV Ovarian Epithelial Cancer2Stage IV Ovarian Germ Cell Tumor2Adenocarcinoma of the Prostate1Brain and Central Nervous System Tumors1Chronic Myeloproliferative Disorders1Gestational Trophoblastic Tumor1Healthy, no Evidence of Disease1Kidney Cancer1

Leading sponsors

Case Comprehensive Cancer Center4Memorial Sloan Kettering Cancer Center4University of Washington4National Cancer Institute (NCI)3Wake Forest University Health Sciences3National Institutes of Health Clinical Center (CC)2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2University of California, Davis2Abramson Cancer Center at Penn Medicine1Alliance for Clinical Trials in Oncology1Barbara Ann Karmanos Cancer Institute1British Columbia Cancer Agency1Centre Oscar Lambret1Dr. Susan Love Research Foundation1Eastern Cooperative Oncology Group1

Trial status mix

COMPLETED27
TERMINATED6
UNKNOWN4
WITHDRAWN3

Phase mix

PHASE112
PHASE211
NA7
EARLY_PHASE11
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.